Professional Documents
Culture Documents
Mehta 2017
Mehta 2017
Mehta 2017
www.elsevier.com/locate/ro
PII: S0037-198X(17)30011-1
DOI: http://dx.doi.org/10.1053/j.ro.2017.04.002
Reference: YSROE50585
To appear in: Seminars in Roentgenology
Cite this article as: Kaushal Mehta, Morgan P. McBee, David C. Mihal and Eric
B. England, Radiographic analysis of Bone Tumors: A systematic approach,
Seminars in Roentgenology, http://dx.doi.org/10.1053/j.ro.2017.04.002
This is a PDF file of an unedited manuscript that has been accepted for
publication. As a service to our customers we are providing this early version of
the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting galley proof before it is published in its final citable form.
Please note that during the production process errors may be discovered which
could affect the content, and all legal disclaimers that apply to the journal pertain.
Title Page
Authors:
1. Kaushal Mehta, MD
Assistant Professor of Radiology
Fellowship Director, Musculoskeletal Radiology
Department of Radiology
University of Cincinnati Medical Center, Cincinnati, OH 45219
2. Morgan P. McBee, MD
Radiology Resident, PGY-5
Department of Radiology
University of Cincinnati Medical Center, Cincinnati, OH 45219
3. David C. Mihal, MD
Radiology Resident, PGY-5
Department of Radiology
University of Cincinnati Medical Center, Cincinnati, OH 45219
4. Eric B. England, MD
Assistant Professor of Radiology
Program Director, Radiology Residency
Department of Radiology
University of Cincinnati Medical Center, Cincinnati, OH 45219
Institution of work:
Department of Radiology
University of Cincinnati Medical Center, Cincinnati, OH 45219
Corresponding author:
Kaushal Mehta, MD
Assistant Professor of Radiology
Department of Radiology, ML 0761
University of Cincinnati Medical Center, Cincinnati, OH 45219
Telephone number: 513-584-2146
Email: kaushal.mehta@uc.edu
Radiographic analysis of Bone Tumors: A systematic approach
Introduction
Bone tumors are a commonly encountered diagnostic dilemma for radiologists. Benign and
abnormalities often related to developmental or inflammatory causes) all fall under the purview
of bone tumors.1 Primary bone tumors are rare; tumor-like conditions, metastatic disease, and
radiography is recommended as the initial imaging modality of suspected bone tumors 1-5
Radiography provides excellent resolution and yields the most useful information about the
imaging findings, clinical information such as the age of the patient, and in some cases histology
is also essential. Rather than discussing an in depth analysis of every bone tumor, we will instead
focus on a systematic approach to the radiographic analysis of bone tumors. The figures and
tables in this article will help readers become familiar with specific radiographic appearances,
location, and age predilection of common bone tumors and help to organize a differential
The two most important features in the analysis and differential diagnosis of a bone tumor are the
age of the patient and the morphological features of the lesion on plain radiographs. When
combined with the location, the differential diagnosis can be narrowed even further and can often
times lead to a single correct diagnosis. The specific features that need to be evaluated are
margins and zone of transition, periosteal reaction, mineralization, tumor location, number and
size of the lesions, and the presence of a soft-tissue component (Fig.1).1-3, 5-8 While these features
were originally described on plain radiography, they can also be applied to computed
tomography (CT) in majority of cases.9 Magnetic resonance imaging (MRI) cannot be used to
assess these features due to its inherent sensitivity, which usually overestimates the
as chondroblastoma can show significant marrow and periosteal edema on MRI making its
appearance aggressive.
Clinical information
Age is the most important clinical clue that can help narrow the differential diagnosis when
encountering a bone tumor. Although there is significant overlap between age groups and
exceptions do occur, the typical age range of different bone tumors is summarized (Table 1).1-3
Primary osteosarcoma and Ewing sarcoma are tumors of children and young adults. Occurrence
cancer and myeloma. Osteosarcomas in this age group are often secondary malignancies, which
develop at the osseous sites of Paget’s disease or previous radiation. Giant cell tumor, a locally
aggressive lesion, almost exclusively occurs in skeletally mature patients (20 to 50 years of age)
with closed epiphyses while a chondroblastoma and unicameral bone cyst occur in skeletally
immature patients (< 20 years old) with open epiphyses. In general, solitary bone lesions
identified in adult patients have a much higher likelihood of being malignant than those found in
pediatric patients.
The gender of the patient usually plays no significant role in narrowing the differential diagnosis
of a bone tumor. The race of the patient can occasionally be helpful in the diagnosis of a bone
tumor, most commonly in Ewing sarcoma, which occurs overwhelmingly in white patients and is
Pain, is the second most important clinical factor after age in differential diagnosis of a bone
lesion. Pain could be a symptom of growing lesions, which include locally aggressive lesions
like osteoblastoma, giant cell tumors, and malignancies. It is also seen with pathological
fractures and neurovascular involvement of the tumor. Osteoid osteoma, typically causes intense
night pain relieved by non-steroidal anti-inflammatory drugs and can be a cause of severe
radiographically similar appearing chondroid lesions like low-grade chondrosarcoma (which can
pathological fracture.13
Margin and zone of transition
The margin of the lesion and zone of transition between lesion and the adjacent bone are key
factors in determining if a lesion is aggressive. A lesion with sharp margins and a narrow
have a sclerotic border. Analysis of the margins is readily performed on radiographs, which are
inexpensive, easily accessible, and provide a concise assessment of lesion behavior on a limited
number of images. A radiographic classification of bone tumor margins has been developed that
identifies three main types.6 Patterns of bone destruction includes geographic, moth-eaten, or
permeative. These patterns reflect the growth rate of lesions, rather than their potential to
A focal, discrete, round or oval shaped lesion is termed geographic (Type I), and shows complete
bony destruction within the lesion with well-defined margins. The borders of geographic bone
destruction are sub-classified into three categories based on their aggressiveness. Type IA
margins are the least aggressive, exhibiting a sclerotic rim (e.g. non-ossifying fibroma (Fig. 2),
fibrous dysplasia, or chondromyxoid fibroma). Type IB margins have no sclerotic rim, while
remaining well defined with a narrow zone of transition, the so-called “punched out” lesion.
These margins indicate indeterminate growth potential and may be seen with benign or
malignant lesions (e.g., giant cell tumor (Fig. 3), aneurysmal bone cyst, multiple myeloma, or
low-grade chondrosarcoma). Type IC margins are poorly defined, with a wide zone of transition,
suggestive of a locally aggressive lesion. Most tumors with type IC margins are malignant (e.g.
transition and a more aggressive pattern. The moth-eaten (Type II) pattern manifests as multiple
ill-defined areas of bony destruction with ragged borders and usually indicates malignancy (e.g.
myeloma, metastases, lymphoma, Ewing sarcoma (Fig.5)). Permeative (Type III) manifests as an
ill-defined lesion with multiple “worm-holes” with a very broad zone of transition, spreading
through marrow space. It is the most highly aggressive pattern of bone destruction and
characteristic of a lesion that is growing rapidly. This usually implies an aggressive malignancy
(e.g. small round blue cell lesions such as lymphoma, leukemia, Ewing sarcoma, or multiple
myeloma (Fig.6)). Caveats include entities such as osteomyelitis, eosinophilic granuloma and
Although there are some exceptions, these features are a good guideline for categorizing lesions
as non-aggressive which would suggest a benign process or as aggressive which would suggest a
malignant process.
Periosteal reaction
Periosteal reaction can be an important radiographic feature that can help characterize a bone
lesion. It often develops because of cortical involvement in response to direct tumor spread,
This reflects the biologic potential of the lesion even though it is less specific than other
the whole bone. This pattern can manifest as a unilamellated, solid, smooth appearance which is
typical of a slow growing, indolent processes such as osteoid osteoma (Fig.7), osteoblastoma,
intermediate aggressive reaction such as that seen in Ewing sarcoma (Fig.8).7 This form can also
fractures.
the lesion breaking through the cortex and growing into the adjacent soft tissues typically
pattern, which is the most aggressive appearance, highly suggestive of malignancy, such as
osteosarcoma (Fig. 9) or Ewing sarcoma. Codman's triangle is the visible portion of the elevated
periosteum (from tumor) where it joins the cortex, acquiring a triangular shape (Fig. 10).1-3, 7
Typically, the Codman triangle is often associated with osteosarcoma, but any aggressive process
that lifts the periosteum can produce this appearance, including benign entities such as sub-
periosteal hematoma and abscess. Complex patterns include a mix of continuous and interrupted
types. In general, a solid periosteal reaction is suggestive of a benign process, while the more
interrupted and complex pattern is suggestive of a greater biologic activity and a more aggressive
lesion. As with many rules in medicine, there are caveats, such as when benign and malignant
processes coexist. This most commonly occurs when there is a fracture or infection in the same
Matrix is found in benign and malignant tumors and does not closely correlate to malignant
potential, but matrix mineralization at radiography has been found to be helpful in distinguishing
different histologic types of primary bone tumors.15 Each type of matrix mineralization shows a
Mature osteoid, or organized bone, shows more orderly, trabecular pattern of ossification and is
characteristic of the benign bone-forming lesions such as osteoblastoma (Fig. 11A). Osteoid
haphazard mineralization, and this pattern is seen in malignant bone-forming tumors like
osteosarcoma (Fig.11B).
configuration that forms around globular cartilage lobules, as seen in cartilaginous tumors like
radiographically and only suggests the histologic nature of the tissue (cartilage) but does not
mineralization that can be uniform or heterogeneous and is classically seen in fibrous dysplasia
(Fig.13).
The gradual increase in mineralization with time is termed “maturation” and can be seen in
tumors such as fibrous dysplasia, non-ossifying fibroma, fibrous cortical defect, osteoid osteoma,
and bone islands.16 This should not be confused with the post-therapeutic response of aggressive
lesions that have responded well to therapy which is usually evident peripherally in lesions. It
should be remembered that the margin classification system discussed in this article applies only
to untreated bone tumors.6 Many lesions of varying cell types do not show any type of internal
matrix, and this is also the case with highly dedifferentiated osteoid or chondroid malignancies.18
Location
The majority of bone tumors have a propensity to occur in characteristic locations in the skeleton
and specific locations within long bones (Table 2). 1-3, 19 Hence, the differential diagnosis can be
refined based on the location, which at times can lead to a specific diagnosis. A well-defined
lucent lesion in the proximal humerus in a young individual, for example, will most likely be a
unicameral bone cyst. The differential diagnosis of a lesion in the calcaneus would be different
from one in the sternum. Most lesions arising in the calcaneus are benign, whereas most lesions
arising in sternum are malignant. Some of the lesions have a strong predilection for specific
locations, such as adamantinoma for the anterior cortex of tibia (Fig. 14), osteoblastoma for the
posterior elements of the spine, or periosteal desmoid for the posterior distal femoral
metaphysis.2
Whether the lesion arises in the axial or appendicular skeleton is also important. Certain tumors
predominate in the region of red marrow as a result of being derived from the cells of marrow or
being transported to this location by vascularity. Multiple myeloma, metastatic disease, Ewing
sarcoma, and lymphoma are some of the tumors that primarily localize to the hematopoietic
marrow.1-3 The distribution of Ewing sarcoma follows the hemopoietically active red marrow,
which is in long bone diaphysis in the skeletally immature patient and subsequently shifts to the
flat bones such as the pelvis and skull when skeletally mature.1-2,19
The majority of the primary bone tumors develop in the region of fastest bone growth
(metaphysis), particularly in the distal femur and proximal tibia. This region has the richest blood
supply and the unique vascular anatomy of looped vessels which promotes slow flow, and
predisposes to metastatic seeding of tumor and infection.2 A lesion in the long bone can show
diaphysis or metaphysis) and in the transverse plane based on the center of the lesion (medullary
process-central versus eccentric, cortical or juxtacortical) (Fig. 15).1-3 For example, aneurysmal
bone cyst, unicameral bone cyst, non-ossifying fibroma, and osteochondroma are all metaphyseal
lesions, but aneurysmal bone cyst is an eccentric medullary lesion (Fig.16A), unicameral bone
cyst is a central medullary lesion (Fig.16B), non-ossifying fibroma is a cortically based lesion,
and osteochondroma is juxtacortical (Fig. 17A). Ewing sarcoma and adamantinoma are both
diaphyseal lesions, but Ewing sarcoma originates in the central medullary cavity while
adamantinoma is cortically based. However, in thin tubular bones such as the fibula and smaller
bones of the hands and feet, the entire diameter of the bone may be involved and it may not be
possible to determine the center of the lesion. Given that the majority of the tumors arise in the
metaphysis or in the diaphysis, the epiphyseal lesions have a limited differential. For example, a
well-defined lucent lesion in the epiphysis of a skeletally immature patient would likely be a
chondroblastoma (Fig. 18A), while in a skeletally mature patient it would likely be a giant cell
tumor. An apophysis is considered as an equivalent of epiphysis and thus we should use the
epiphyseal differential for lesions in sites such as the greater trochanter and tibial tuberosity. In
flat bones, epiphyseal-equivalent areas exist beneath the articular cartilage in bones of the pelvis
and shoulder girdle. Similar “epiphyseal” lesions may develop in the patella and small bones of
the wrist and foot (Fig.19).2 In the spine, hemangioma is the most common benign tumor which
localizes to the vertebral body.20 Other tumors that localize to the vertebral body are myeloma,
lymphoma, metastasis (Fig. 20A), and these are commonly multiple. Paget’s disease is a
common differential consideration when evaluating a sclerotic vertebral body lesion and is
commonly solitary (Fig. 20B). The posterior vertebral elements are mostly affected by benign
Cortical involvement
The cortex can serve as a barrier to expansion of tumors. In addition to lesions that arise in the
cortex, the cortex may be affected by medullary and juxta-cortical lesions. When a slow growing
medullary lesion expands, it can cause lobulated erosion along the inner wall of the cortex
termed endosteal scalloping (Fig. 21).2 With continued growth, medullary lesions may show
cortical expansion and thinning with a resultant ballooned appearance, usually seen with benign
processes that grow slowly enough to let the cortex remain intact such as aneurysmal bone cyst
(Fig. 16A). Lesions that produce a large degree of cortical expansion and thinning predispose to
complications such as pathological fracture, limb length discrepancy, and destruction of the
articular surface as can be seen in some cases of giant cell tumor, predisposing to osteoarthritis.
Malignancies are more likely to progress rapidly and result in cortical destruction. Juxta-cortical
lesions such as parosteal osteosarcoma (Fig. 17B), periosteal chondroma, and juxta-cortical
chondrosarcoma may erode through the outer margin of the cortex and result in saucerization
(Fig.22).2, 8 A cortical lesion like osteoid osteoma can result in proliferation of cortical bone and
thickening, while cortical lesions like lung metastasis, osteofibrous dysplasia, and adamantinoma
The presence of a soft tissue mass associated with a bone lesion increases the likelihood that the
lesion is malignant. Exceptions include giant cell tumor, which can be locally aggressive but is
considered benign, and osteomyelitis. Tumors that commonly show a soft tissue component
include lymphoma (Fig. 23), metastases, and primary bone sarcomas.22-23 Cross-sectional
imaging may help differentiate neoplasm from infection, because infection would be expected to
show associated inflammatory changes which are generally more prominent than seen with a
neoplastic process.5,24
In general, primary malignant bone tumors are larger than benign tumors. As a rule, lesions
larger than 6 cm are statistically more likely to be malignant, although size alone is not an
adequate predictor of malignancy or benignity and additional radiographic features such as rate
of growth and cortical destruction have to be taken into account.8, 24 Several of the lesions have
size criteria that help in differentiation. A lesion size can help differentiate osteoid osteoma from
osteoblastoma. The lucent nidus of osteoid osteoma will rarely measure greater than 2 cm in
diameter. It has been suggested that lesions less than 1.5 cm are usually osteoid osteoma, while
larger than 1.5 cm are usually osteoblastoma.25-26 Benign lesions like fibroxanthomas can be sub-
categorized by the length of the lesion, with lesion less than 3 cm termed as fibrous cortical
defect and longer than 3 cm termed as non-ossifying fibroma.2, 27 A chondroid lesion measuring
less than 2 cm in size in the appendicular skeleton is most likely an enchondroma, while the risk
of it being chondrosarcoma increases if if the lesion measures greater than 5 cm.13,27 Periosteal
lesions less than 3 cm at pathology are mostly benign, whereas lesions greater than 5 cm are
malignant.19
Primary bone tumors are solitary occurrences, while other abnormalities may be multiple (Table
3).1-3 Although both benign and malignant tumors can be multifocal, benign lesions tend to have
a symmetrical distribution.
The growth rate of a lesion is of paramount importance in assessing the aggressiveness of the
lesion. Benign tumors usually grow slower than malignancies, or remain stable over a long
period of time. Growth rate can be used to distinguish a slow growing benign bone forming
tumor like osteoblastoma from a rapidly growing osteosarcoma, which at times can be difficult
enchondroma from low-grade chondrosarcoma in the long bones which otherwise appear similar
radiographically and histologically. Additional features which can be used to distinguish these
two tumors are change in the morphology specifically endosteal scalloping involving more than
two-third of the cortical thickness, change in mineralization pattern, and soft tissue extension
inexpensive, easily available, and best for assessment of morphological characteristics of the
tumor. The margin classification system described in this article is designed primarily for use
with radiography. Limitations of radiography include anatomic overlap that can obscure
abnormalities, limited capacity to evaluate soft tissues and limited contrast for lesion detection in
the trabecular bone. It is estimated that about 40-50% of the trabecular bone must be lost before a
lesion can be detected on the radiograph.6 MRI and CT imaging may provide additional
information by virtue of their multi-planar capability and better soft tissue characterization.
CT in particular is useful for assessing faint matrix mineralization, periosteal reaction, cortical
involvement or cortically based lesions such as osteoid osteoma, detection of lesions in the flat
bones and cystic and fatty components of the lesion.28 MRI is superior to CT for evaluating the
extent of tumor in the medullary cavity and extra-osseous tumor volume, including relationship
with surrounding neurovascular structures and is the modality of choice for staging and assessing
post-treatment response.4, 29-30 However, it should be remembered that the MRI appearance of the
majority of bone tumors is non-specific and should always be assessed concurrently with plain
Bone scintigraphy is a highly sensitive but relatively non-specific technique. Its main role is in
detection of suspected metastases in the whole skeleton. It may also be helpful in the detection of
osteoid osteomas ("double density sign" is present in about 50% of cases and is highly
Radiography remains the most important imaging modality in the characterization of bone
tumors despite the availability of advanced imaging techniques. CT and MRI can provide useful
a systematic approach is followed, correlating patient age with a careful assessment of imaging
features including such as location and margin characterization, the differential diagnosis can be
References:
4. Morrison WB, Dalinka MK, Daffner RH et al. Bone tumors. ACR appropriateness
criteria. Reston, VA: American College of Radiology, 1-5, 2000
5. Priolo F, Cerase A. The current role of radiography in the assessment of skeletal tumors
and tumor-like lesions. Eur J Radiol; 27(suppl 1): S77–S85, 1998
6. Madewell JE, Ragsdale BD, Sweet DE. Radiologic and pathologic analysis of solitary
bone lesions. I. Internal margins. Radiol Clin North Am19:715–748, 1981
7. Ragsdale BD, Madewell JE, Sweet DE. Radiologic and pathologic analysis of solitary
bone lesions. II. Periosteal reactions. Radiol Clin North Am19:749–783, 1981
8. Kricun ME. Radiographic evaluation of solitary bone lesions. Orthop Clin North Am
14:39–64,1983
9. Brown KT, Kattapuram SV, Rosenthal DI. Computed tomography analysis of bone
tumors: patterns of cortical destruction and soft tissue extension. Skeletal Radiol; 15:448–
451, 1986
10. Hayes CW, Conway WF, Sundaram M. Misleading aggressive MR imaging appearance
of some benign musculoskeletal lesions. Radiographics 12:1119–1136,1992
11. Reinus WR, Gilula LA. Radiology of Ewing’s sarcoma: intergroup Ewing’s Sarcoma
Study (IESS). Radiographics 4:929–44, 1984
12. Helms CA. Osteoid osteoma. The double density sign. Clin Orthop Relat Res.
Sep;(222):167-73, 1987
13. Murphey MD, Flemming DJ, Boyea SR, et al. Enchondroma versus chondrosarcoma in
the appendicular skeleton: differentiating features. Radiographics;18:1213–37, 1998
14. Lodwick GS, Wilson AJ, Farrell C, et al. Determining growth rates of focal lesions of
bone from radiographs. Radiology 134:577–583, 1980
15. Sweet DE, Madewell JE, Ragsdale BD. Radiologic and pathologic analysis of solitary
bone lesions. III. Matrix patterns. Radiol Clin North Am19:785–814, 1981
16. Yanagawa T, Watanabe H, Shinozaki T, et al. The natural history of disappearing bone
tumours and tumourlike conditions. Clin Radiol 56:877–886, 2001
17. Costelloe CM, Madewell. Radiography in the initial diagnosis of primary bone tumors.
AJR Am J Roentgenol Jan;200(1): 3-7, 2013
18. Morley N, Omar I. Imaging evalution of musculoskeletal tumors. Cancer Treat Res
162:9-29, 2014
19. Unni KK, Inwards CY. Dahlin’s bone tumors. 6th edition. Philadelphia: Lippincott; 2010.
20. Rodallec MH, Feydy A, Larousserie F et al. Diagnostic imaging of solitary tumors of
the spine: what to do and say. Radiographics Jul-Aug;28(4):1019-41, 2008
21. Levine SM, Lambiase RE, Petchprapa CN. Cortical lesions of the tibia: characteristic
appearances at conventional radiography. Radiographics 23:157–177, 2003
22. Murphey MD, Robbin MR, McRae GA et al. The many faces of osteosarcoma.
Radiographics 17:1205–1231, 1997
23. Mulligan ME. Myeloma and lymphoma. Semin Musculoskelet Radiol 4:127–135, 2000
24. Nichols RE, Dixon LB et al. Radiographic analysis of solitary bone lesions. Radiol Clin
North Am. Nov; 49(6):1095-1114, 2011
25. White LM, Kandel R. Osteoid-producing tumors of bone. Semin Musculoskelet Radiol
4(1):25–43, 2000
26. Chai JW, Hong SH, Choi JY, et al. Radiologic diagnosis of osteoid osteoma: from
simple to challenging findings. Radiographics 30:737–49, 2010
27. Miller TT. Bone tumors and tumorlike conditions: analysis with conventional
radiography. Radiology; 246(3):662–74, 2008
28. Zimmer WD, Berquist TH, McLeod RA, et al. Bone tumors: magnetic resonance imaging
versus computed tomography. Radiology; 155:709 –718, 1985
29. Panicek DM, Gatsonis C, Rosenthal DI, et al. CT and MR imaging in the local staging of
primary malignant musculoskeletal neoplasms: report of the Radiology Diagnostic
Oncology Group. Radiology;202:237–246, 1997
30. Sundaram M, McLeod RA. MR imaging of tumor and tumorlike lesions of bone and soft
tissue. AJR Am J Roentgenol. Oct;155(4):817-24,1990
31. Stacy GS, Mahal RS, Peabody TD. Staging of bone tumors:
a review with illustrative examples. AJR Am J Roentgenol. Apr;186(4):967-76, 2006
Tables
Table 1. Age Distribution of Common Bone Lesions
Lesion Locations
Figure 4 Type 1C geographic lesion (A) Diagram shows an ill-defined lucent lesion. (B)
Radiograph shows an ill-defined lytic lesion with wide zone of transition (white arrows) in the
meta-diaphysis of distal femur in a 18-year-old male with osteosarcoma. Also note extension to
the cortex (white arrowhead) and associated lamellated periosteal reaction (black arrows).
Figure 5 Type II moth-eaten lytic lesion (A) Diagram shows ill-defined patchy lucent areas in the
medullary cavity. (B) Radiograph shows an ill-defined patchy lytic lesion in the proximal fibula
with poorly defined wide zone of transition (white arrows) in a 20-year-old male with Ewing
sarcoma. Also note the multilamellated periosteal reaction (black arrows) which extends distal
to the identifiable extent of the lesion in the medullary cavity suggesting a possible longer
segment involvement.
Figure 6 Type III permeative lytic lesion (A) Diagram shows numerous ill-defined tiny patchy
lucencies in the medullary cavity. B: Radiograph shows a permeative pattern lytic lesion
involving the medullary cavity and cortex with wide zone of transition (white arrows) in the
diaphysis of humerus in a 52-year-old female with multiple myeloma. Note the pathologic
fracture of the distal humerus (black arrows).
Figure 7 Solid periosteal reaction (A) Diagram shows a solid periosteal reaction (black arrow).
(B) Radiograph shows a solid, smooth periosteal reaction (white arrow) which manifests as
cortical thickening in the diaphysis of tibia in a 16-year-old male with osteoid osteoma. Also
note the small lucent nidus (black hollow arrow).
Figure 8 Multilamellated periosteal reaction (A) Diagram shows a multilamellated periosteal
reaction (black arrow) (B) Radiograph shows a multilamellated, onion skin type periosteal
reaction (white arrow) in the diaphysis of fibula in a 14-year-old male with Ewing sarcoma. See
also Figure 5.
Figure 9 Sunburst or spiculated periosteal reaction (A) Diagram shows a sunburst periosteal
reaction (black arrow) (B) Radiograph shows a severe sunburst periosteal reaction (white
arrows) in the distal femur of a 12-year-old male with osteosarcoma. Also note the large cloud-
like osteoid matrix (white arrowheads)
Figure 10 Codman triangle (A) Diagram shows an elevated periosteum forming an angle with
the cortex (black arrows). B: Radiograph shows elevated periosteum forming a codman triangle
(white arrows) in the mid femoral diaphysis of a 9-year-old female with Ewing sarcoma. Note
the cortical destruction and large soft tissue mass (white arrowheads).
Figure 11 Osteoid matrix. (A) Radiograph shows a homogeneous area of sclerosis (white
arrowhead) suggestive of a mature osteoid in the distal phalanx of the thumb in a 15-year-old-
female with osteoblastoma. Also note the radiolucent nidus (black hollow arrow) (B) Radiograph
shows fluffy, ill-defined amorphous osteoid matrix (white arrow) in the distal femur of a 15-
year-old-male with osteosarcoma. Note the large soft tissue mass (black arrow). Please also
refer to image 9.
Figure 12 Chondroid matrix. Radiograph shows ring-and-arc type chondroid matrix (white
arrows) in the humeral diaphysis of a 30-year-old-male with enchondroma.
Figure 13 Groundglass matrix. Radiograph shows groundglass matrix (arrows) in a geographic
Type1A lesion in the proximal femoral diaphysis of a 40-year-old-male with fibrous dysplasia.
Figure 14 Cortical lesion: Radiograph shows an ill-defined cortically-based lesion in the anterior
tibia diaphysis with patchy areas of sclerosis and lysis in a 30-year-old-male with
adamantinoma. This lesion has a strong predilection for anterior tibial cortex location.
Figure 15 Diagram showing location of common bone tumors and some tumor-like conditions in
long bones in both transverse and longitudinal planes in < 30 years and > 30 years age groups.
AA= adamantinoma, ABC= aneurysmal bone cyst, CB=chondroblastoma, CMF=chondromyxoid
fibroma, CS=chondrosarcoma, EC=enchondroma, EG= eosinophilic granuloma, ES=Ewing
sarcoma, FCD=fibrous cortical defect, FD=fibrous dysplasia, G=geode, GCT=giant cell tumor, M=
metastasis, MM=multiple myeloma, NOF= nonossifying fibroma, OM= osteomyelitis,
OO=osteoid osteoma, OC= osteochondroma, OS= osteosarcoma, RCT=round cell tumors,
SF=stress fracture.
Figure 16 Eccentric versus Central lesions: A. Aneurysmal bone cyst: Radiograph shows an
eccentrically located, expansile, multiloculated, lytic lesion with cortical thinning (white arrows)
in the proximal tibial metaphysis extending to the epiphysis of a 20-year-old female. B.
Unicameral bone cyst: Radiograph shows a centrally located, expansile, lytic lesion (black
arrows) in the proximal humerus meta-diaphysis in a 14-year-old-male. Note also the
pathological fracture (white arrowhead) and fallen fragment sign (black hollow arrow),
classically seen with this lesion.
Figure 17 Juxta-cortical lesions. (A) Osteochondroma: Radiograph shows a pedunculated lesion arising
from the proximal tibial metaphysis which is pointed away from the epiphysis and has a calcified
chondral cap (white arrow) in a 14-year-old-male with osteochondroma. Note remodeling of the fibular
shaft due to long-standing pressure effect from the osteochondroma (black arrow). (B) Parosteal
osteosarcoma: Radiograph shows an ill-defined juxta-cortical osteoid forming lesion (white arrowheads)
causing saucerization ( black hollow arrow) of the posterior cortex of distal femoral metaphysis in a 24-
year-old-male with parosteal osteosarcoma (white arrowheads).This is the most common location of
parosteal osteosarcoma.
Figure 18 Epiphyseal lesion. (A) Chondroblastoma: Radiograph shows a geographic lesion with
thin peripheral sclerosis in the proximal humeral epiphysis of a 14-year-old-female (white
arrows). (B) Clear cell chondrosarcoma: Radiograph shows a geographic lesion with peripheral
sclerosis and central calcifications in femoral head epiphysis of a 50-year-old-male (black
arrows).
Figure 19 Epiphyseal equivalent location: Radiograph shows a geographic, slightly expansile
lesion in the talus of a 16-year-old male with chondroblastoma (white arrows).
Figure 20 Spine lesion. (A) Radiograph demonstrates multifocal ill-defined sclerotic lesions
throughout the spine in a 60-year-old-male with osteoblastic metastasis from prostate
carcinoma. (B) Radiograph demonstrates diffuse sclerosis and enlargement of the L1 vertebral
body which has a picture frame appearance in a 55-year-old-male with Paget’s disease (white
arrows).
Figure 21 Endosteal scalloping. Radiograph shows multiple geographic lytic lesions in the ulnar
shaft causing endosteal scalloping in a 50-year-old-female with multiple myeloma (white
arrows).
Figure 22 Saucerization. Radiograph shows a soft tissue mass (white arrowheads) with foci of
ring-and-arc chondral matrix calcification (blackarrow) causing saucerization of the femoral
cortex (white arrows) in a 27-year-old-female with Juxta-cortical chondrosarcoma.
Figure 23 Soft tissue mass. Radiograph shows a soft tissue mass superior to the shoulder (white
arrows) and moth eaten appearance of the acromion (black arrows) in a 28-year-old male with
lymphoma. Please also refer to Figures 10-11.